Skip to main content
Premium Trial:

Request an Annual Quote

20/20 GeneSystems Gets $2M from NIST for Predictive Chemo Dx

NEW YORK (GenomeWeb News) - 20/20 GeneSystems said today that it has been awarded $1.9 million through the National Institute of Standards and Technology's Advanced Technology Program to develop a new technique for profiling cancer tumors that would help predict the effectiveness of chemotherapy drugs.
20/20 GeneSystems, based in Rockville, Md., said its method, called layered expression scanning-diagnostic, or LES-Dx, allows biomarkers from biopsy tissues to be mapped to a layered array that is read using “sophisticated microscopes and digital imaging techniques.”
CEO Jonathan Cohen said that when the technology is fully developed, it is expected to “significantly improve the response rates of several FDA approved targeted cancer therapies.”

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.